Rio Tinto Venture Nuton Completes Non-brokered Private Placement Financing With Regulus

Rio Tinto venture Nuton LLC said that it has completed a non-brokered private placement financing with Regulus Resources for a strategic investment of US$15 million.

As per the Financing, Rio Tinto venture Nuton was issued 20.06 million common shares in the capital of Regulus at an issuance price equal to C$1.02 per Common Share.

Upon completion of the Financing, Rio Tinto venture Nuton acquired beneficial ownership and control over 20.06 million Common Shares representing 16.1% of the issued and outstanding Common Shares on completion on a non-diluted basis.

Regulus and Nuton have reached a collaboration agreement wherein Nuton was granted certain investor rights, including allowing Nuton to maintain its equity interest in Regulus if it maintains said interest above 10%. Additionally, Nuton shall be allowed to nominate a director to the board of directors of Regulus.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT